Navigation Links
Growers rally behind purple flowers to support TGen cancer research
Date:4/21/2011

PHOENIX, Ariz. April 20, 2011 A group of Ohio greenhouse growers hopes a "shock wave" of purple flowers will eventually roll across America in support of scientific research to end pancreatic cancer.

Starting May 1, the Maumee Valley Growers and 16 affiliated northwest Ohio greenhouse retailers will raise funds for the Phoenix-based Translational Genomics Research Institute (TGen) by selling "denim shock wave petunias" through a program called Plant Purple-Grow Hope.

"We are delighted to be the first grower organization in America to partner with TGen in support of this important cancer research," said Joe Perlaky, Program Manager for the Maumee Valley Growers.

Plant Purple-Grow Hope will set aside 50 cents for every 4.5-inch purple petunia pot sold by the non-profit Maumee Valley Growers and their partners, through June 30. Denim shock wave petunias were selected for the campaign because of their ease of care and purple hue, which is the color of pancreatic cancer awareness.

Kelly Kinney of Toledo, Ohio, initiated Plant Purple-Grow Hope in memory of her brother, Bret Connors, a Scottsdale, Arizona, resident who lost his three-year battle with pancreatic cancer in 2009.

"I've always found comfort in nature," said Kinney, whose brother was an avid outdoorsman. "Then I thought of growing hope."

After being turned down by several retailers, Kinney eventually found a receptive ear in the owner of a nursery, associated with the Maumee Valley Growers, whose mother died of pancreatic cancer.

Michael Bassoff, President of the TGen Foundation, enthusiastically embraced what he described as Kinney's innovative idea. "We are thrilled that gardeners and homeowners throughout Ohio will have the opportunity to join the fight against pancreatic cancer in such an elegant and environmentally-friendly way," Bassoff said.

To launch a Plant Purple-Grow Hope program in your community, please contact Erin Massey at the TGen Foundation at 602-343-8470.

Proceeds will fund TGen's globalCure initiative, an alliance of some of the world's foremost scientists, physicians and pancreatic cancer advocates that aims to find a cure for this disease. Pancreatic cancer annually takes the lives of more than 35,000 Americans, making it the fourth-leading cause of cancer death.

Kinney said the hope is to eventually roll the program out to growers and nurseries across the nation. "I just really wanted this first year to work on awareness, getting the program off the ground and supporting globalCure," Kinney said.

The backbone of globalCure is an alliance announced in March between TGen and TGen Drug Development's Pancreatic Cancer Research Team (PCRT). PCRT includes leading pancreatic cancer scientists, physicians and researchers, armed with the most technologically advanced tools and resources, at 46 top-flight medical research institutions worldwide.

"This has been a wonderful collaboration from the start," said Perlaky of the non-profit Maumee Valley Growers, whose efforts in time and expertise are supported by a grant from the University of Toledo.

"However, none of this would have been possible without the guidance of Kelly Kinney, whose passion for the cure encouraged our marketing committee to develop this program of public awareness and education," Perlaky said.

Kinney said she believes Plant Purple-Grow Hope is a fitting way to preserve the memory of her brother, Bret, who is survived by his wife and three sons. For more on Bret's life, please visit: www.tgenfoundation.org/NetCommunity/Page.aspx?pid=794.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. Reflective film can boost profits for apple growers
2. Growers can boost benefits of broccoli and tomatoes
3. Rice growers turn to computer for advice, predictions
4. Rice hulls a sustainable drainage option for greenhouse growers
5. Willow cut-stem growers surveyed
6. Implants mimic infection to rally immune system against tumors
7. Rabbits on the back foot -- but naturally theyre fighting back
8. Ability to literally imagine oneself in anothers shoes may be tied to empathy
9. Study shows pine bark naturally relieves symptoms of acute hemorrhoids
10. Modern man found to be generally monogamous, moderately polygamous
11. Reinventing the wheel -- naturally
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, Biometrics & ... & Other Service  The latest report from ... of the global Border Security market . Visiongain ... billion in 2016. Now: In November 2015 ... and hardware technologies for advanced video surveillance. ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of ... the latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Medical Display- Ampronix News ...
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: